Question 1 of 27
(demo test)

Product Demo for Clinical

In RTOG 0236 (Timmerman et al. JAMA 2010), a phase II trial treating patients with inoperable T1-2 non-small cell lung cancer with stereotactic body radiotherapy, what was the prescribed dose when the trial initiated?

Heads up! You can use keyboard for test navigation: press for Next, for Previous, M for Mark/Unmark, P for Pause, R for Review, A,B,C,... or 1,2,3,... to select answer.